Viruses, Vol. 15, Pages 43: Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation
Viruses, Vol. 15, Pages 43: Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation
Viruses doi: 10.3390/v15010043
Authors:
RuthMabel Boytz
Scott Seitz
Emily Gaudiano
J. J. Patten
Patrick T. Keiser
John H. Connor
Arlene H. Sharpe
Robert A. Davey
Viral pathogens with the potential to cause widespread disruption to human health and society continue to emerge or re-emerge around the world. Research on such viruses often involves high biocontainment laboratories (BSL3 or BSL4), but the development of diagnostics, vaccines and therapeutics often uses assays that are best performed at lower biocontainment. Reliable inactivation is necessary to allow removal of materials to these spaces and to ensure personnel safety. Here, we validate the use of gamma irradiation to inactivate culture supernatants and pellets of cells infected with a representative member of the Filovirus and Coronavirus families. We show that supernatants and cell pellets containing SARS-CoV-2 are readily inactivated with 1.9 MRad, while Ebola virus requires higher doses of 2.6 MRad for supernatants and 3.8 MRad for pellets. While these doses of radiation inactivate viruses, proinflammatory cytokines that are common markers of virus infection are still detected with low losses. The doses required for virus inactivation of supernatants are in line with previously reported values, but the inactivation of cell pellets has not been previously ...
Source: Viruses - Category: Virology Authors: RuthMabel Boytz Scott Seitz Emily Gaudiano J. J. Patten Patrick T. Keiser John H. Connor Arlene H. Sharpe Robert A. Davey Tags: Article Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | Ebola | Ebola Vaccine | Filovirus | SARS | Vaccines | Virology